Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. cytotoxic
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Cytotoxic Articles & Analysis

76 news found

Amerigo Scientific Delivers Highly Efficient Transfection Reagents Coming with Detailed Selection Guide

Amerigo Scientific Delivers Highly Efficient Transfection Reagents Coming with Detailed Selection Guide

The premium transfection reagents from Amerigo Scientific are well-known for high effectiveness, minimal cytotoxicity, and versatility across a wide array of cell lines. As these reagents are engineered to optimize the cellular uptake of DNA, RNA, siRNA, and various types of nucleotides, researchers can obtain reliable transfection results with little effort. ...

ByAmerigo Scientific


CD Bioparticles Introduces Endotoxin Free Silver Nanoparticles for Advanced Biomedical Research

CD Bioparticles Introduces Endotoxin Free Silver Nanoparticles for Advanced Biomedical Research

BS-100-EF) are ideal for sensitive applications where minimal levels of contaminants are required, such as cytotoxicity studies, immunological studies and sterility testing. These nanoparticles are also well suited for conjugate development for blotting and electron microscopy applications. ...

ByCD Bioparticles


CD Formulation Is A Reliable Provider of Customized Drug Conjugates Services

CD Formulation Is A Reliable Provider of Customized Drug Conjugates Services

These sophisticated compounds elegantly bind monoclonal antibodies to cytotoxic agents via linkers, targeting specific antigens while minimizing systematic exposure. This technique combines the selectivity of antibodies with the potency of cytotoxic drugs, allowing for a highly focused approach to disease management, especially in oncology research. ...

ByCD Formulation


Comparison of the Rapid Bactericidal Efficacy of Commercially Available Surgical Solutions

Comparison of the Rapid Bactericidal Efficacy of Commercially Available Surgical Solutions

Introduction Intraoperative irrigation is a commonly used method aimed at reducing microbial burden by removing tissue debris, metabolic waste, and tissue exudate from the surgical field prior to site closure.1 With the absence of universally established standard of care and robust clinical data, the selection of appropriate irrigation solution remains a topic of debate. Isotonic saline has ...

BySanara MedTech Inc.


Protheragen-ING Lab, a Trustworthy GLP Service Provider, Unveils Its Cutting-Edge Medical Device Services

Protheragen-ING Lab, a Trustworthy GLP Service Provider, Unveils Its Cutting-Edge Medical Device Services

Protheragen-ING Lab's expert team of scientists and technicians are experienced in conducting a wide range of safety tests, including biocompatibility, cytotoxicity, genotoxicity, and hemocompatibility testing, among others. ...

ByProtheragen-ING


Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included   

Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included  

This reagent has become increasingly popular in bioorthogonal chemistry, particularly in the field of antibody-drug conjugates (ADCs), a promising class of therapeutics that combines the targeting ability of antibodies with the potency of cytotoxic drugs. Tetrazines, on the other hand, serve as highly reactive dienophiles in inverse-electron demand Diels-Alder reactions with ...

ByAlfa Chemistry


Biopharma PEG Assists ADC Development with Monodispersed PEGs

Biopharma PEG Assists ADC Development with Monodispersed PEGs

Notable PEGs include mPEG36-NH2, NH2-PEG24-COOH, OH-PEG9-OH, mPEG8-SPA, and more.ADCs represent a cutting-edge approach to cancer treatment, combining the specificity of monoclonal antibodies with the potency of cytotoxic drugs. The choice of linker molecules plays a crucial role in determining the overall success of ADCs. ...

ByBiopharma PEG Scientific Inc


CD Formulation Provides In Vitro Cytotoxicity Testing for Microspheres and Microneedles   

CD Formulation Provides In Vitro Cytotoxicity Testing for Microspheres and Microneedles  

In collaboration with renowned research institutions, CD Formulation has created an in vitro cytotoxicity testing platform specifically designed for microspheres and microneedles. ...

ByCD Formulation


Semper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc

Semper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc

” Tevogen Bio is a clinical-stage specialty immunotherapy company harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders with the aim of addressing the significant unmet needs of large patient ...

ByTevogen Bio


CD Formulation Empowers High-volume Manufacturing of Microspheres

CD Formulation Empowers High-volume Manufacturing of Microspheres

In addition to microsphere mass production, CD Formulation has expanded its expertise to include analytical testing, formulation development, stability testing, in vitro cytotoxicity testing, and ...

ByCD Formulation


CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications

CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications

Microspheres & Microneedles In Vitro Release TestingThe microsphere and microneedle in vitro release test provided by CD Formulation is to test and evaluate the release amount and release rate of the drug within a certain period of time after administration, and to investigate the release behavior of the drug carrier. In Vitro Cytotoxicity Testing for Microspheres & ...

ByCD Formulation


Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials

Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials

The featured vaccine products supplied by Alfa Chemistry are listed as below: Nucleic Acid Delivery ExcipientsNucleotide vaccines, including mRNA vaccines with their intracellular antigen synthesis, have been shown to be potent activators of a cytotoxic immune response. However, the intracellular delivery of mRNA vaccines to the cytosol of antigen presenting immune cells remains ...

ByAlfa Chemistry


CEPI partners with Japan’s NEC Group to develop artificial intelligence-designed broadly protective betacoronavirus vaccine

CEPI partners with Japan’s NEC Group to develop artificial intelligence-designed broadly protective betacoronavirus vaccine

I am confident that our unique approach in identifying and selecting antigens that could elicit broader cytotoxic T cell and antibody responses is well positioned to help create broadly protective betacoronavirus vaccines that could protect the global population against multiple betacoronavirus threats on a long-term ...

ByNEC OncoImmunity AS 


Context Therapeutics® Reports Encouraging Preliminary Phase 2 Data for ONA-XR in Metastatic Breast Cancer

Context Therapeutics® Reports Encouraging Preliminary Phase 2 Data for ONA-XR in Metastatic Breast Cancer

“There is a clear unmet need in metastatic endometrial cancer for a therapeutic option after primary or secondary chemotherapy treatment that can meaningfully delay disease progression without debilitating side effects prior to the next round of cytotoxic therapy,” said Lehr. “We believe that dual targeting of both the progesterone receptor and estrogen receptor ...

ByContext Therapeutics Inc.


Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process

Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process

FDA-approved fusion proteins to date are used as agonists of receptor function, such as romiplostim and alefacept; as antagonists that block receptor function, such as etanercept, belatacept, abatacept, lilocept, and aflibercept; or as a direct cytotoxic agent, such as denileukin-diftitox. Meanwhile, a large number of potential candidate peptides targeting the metabolic, ...

ByCreative Proteomics


LIXTE Biotechnology Holdings to Present at Planet MicroCap Showcase: VIRTUAL 2022 Investor Conference

LIXTE Biotechnology Holdings to Present at Planet MicroCap Showcase: VIRTUAL 2022 Investor Conference

LB-100 has potential widespread use as an anti-cancer agent when used alone and in combination with standard anti-cancer therapies, including cytotoxic drugs, radiation, and immune checkpoint blockers. To view LIXTE Biotechnology Holdings' presentation at the Planet MicroCap conference, register in advance at: https://planetmicrocapshowcase.com/signup The Planet MicroCap ...

ByLIXTE Biotechnology Holdings, Inc.


Exclusive License Agreement With Case Western Reserve University for Core-NK Platform (Supplementary Announcement)

Exclusive License Agreement With Case Western Reserve University for Core-NK Platform (Supplementary Announcement)

The expanded CORE-NK cells exhibit enhanced cytotoxicity, metabolism, and expression of activating receptors compared to fresh, activated NK cells. ...

ByChimeric Therapeutics


Exclusive License Agreement With Case Western Reserve University for Core-NK Platform

Exclusive License Agreement With Case Western Reserve University for Core-NK Platform

The expanded CORE-NK cells exhibit enhanced cytotoxicity, metabolism, and expression of activating receptors compared to fresh, activated NK cells. ...

ByChimeric Therapeutics


Synaffix Licenses CliCr Chemistry from Cristal Therapeutics to Fortify Best-in-Class ADC Technology Offering

Synaffix Licenses CliCr Chemistry from Cristal Therapeutics to Fortify Best-in-Class ADC Technology Offering

This further expands the GlycoConnect™ ADC tool kit by significantly enhancing the versatility across cytotoxic payloads and supports further expansion into antibody-based targeted gene therapy and immune cell engager ...

BySynaffix BV


Lixte Biotechnology announces approval of a phase 1B/2 Randomized Trial of Doxorubicin +/-LB-100 In Advanced Soft Tissue Sarcomas to Be Conducted By the Spanish Sarcoma Group

Lixte Biotechnology announces approval of a phase 1B/2 Randomized Trial of Doxorubicin +/-LB-100 In Advanced Soft Tissue Sarcomas to Be Conducted By the Spanish Sarcoma Group

Doxorubicin alone has been the cornerstone of first line treatment of ASTS for over 40 years, with little therapeutic gain from adding cytotoxic compounds to or substituting other cytotoxic compounds for doxorubicin. ...

ByLIXTE Biotechnology Holdings, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT